Callidus Capital Corp (TSE:CBL - Get Free Report)'s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$21.56 and traded as low as C$21.52. Callidus Capital shares last traded at C$21.53, with a volume of 200 shares.
Callidus Capital Stock Performance
The company has a market cap of C$1.23 billion and a PE ratio of -5.12. The company has a debt-to-equity ratio of 1,111.72, a quick ratio of 0.45 and a current ratio of 0.78. The firm has a fifty day moving average of C$21.56.
Callidus Capital Company Profile
(
Get Free Report)
The fund investing in exchange traded funds (ETFs) that invest in Canadian, U.S. and international fixed income and equity securities. The fund provide a balance between longterm capital appreciation and income with an emphasis on longterm capital appreciation.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Callidus Capital, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Callidus Capital wasn't on the list.
While Callidus Capital currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.